Veterinary Medicine Information website

NOBIVAC GUMBORO+ND ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Not authorised
  • Infectious bursal disease virus, strain D78, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
Download as PDF

Product identification

Medicine name:
NOBIVAC GUMBORO+ND ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Infectious bursal disease virus, strain D78, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain D78, Inactivated
    12.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas M.A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 7047/Κ2170/09-05-1985/K-0028101
Date of authorisation status change: